GSK chief science officer leaves to join US startup
GSK
1,342.50p
17:00 27/12/24
0.22%
3.00p
GlaxoSmithKline said it had appointed Tony Wood as chief scientific officer designate after Hall Barron said he was resigning the post to run a new privately owned start-up biotech company.
.
FTSE 100
8,149.78
16:54 27/12/24
n/a
n/a
FTSE 350
4,495.62
16:29 27/12/24
n/a
n/a
FTSE All-Share
4,453.14
17:05 27/12/24
n/a
n/a
Pharmaceuticals & Biotechnology
20,065.81
16:29 27/12/24
0.00%
20,065.81
Wood, who joined GSK from Pfizer in 2017, will take over on August 1. Barron is joining Altos Labs, a new biotech company based in San Francisco, California as chief executive and co-chair.
Altos is focused on the biology of cellular rejuvenation programming with the goal of reversing disease, GSK said.